Adherence

E-prescriptions boost adherence data

Deborah Weinstein May 22, 2012

A new study by Surescripts, the nation's largest e-prescription network, suggests that saving patients the trouble of toting a prescription to a store increases the likelihood that they will get it filled and take their meds.

RX-to-OTC proposal gets mixed reviews

Deborah Weinstein May 14, 2012

Industry and physician groups expressed wary support for the FDA's "new paradigm" drug proposal, which would create a nonprescription "Behind the Counter" class of drugs available through pharmacists.

Genentech's mind-tapping science moves needle on Pulmozyme, Tamiflu

James Chase March 28, 2012

Genentech is thinking outside the traditional focus group to understand patients, helping address the long-standing business challenges of adherence and brand preference, the firm says.

Study shows prescription gender gap

Deborah Weinstein March 21, 2012

Women are simultaneously given more drugs than men and undertreated, according to a study Medco and the Society of Women's Health Research.

Pfizer's Lipitor share slips, casting doubt on power of a loyalty program to save the brand

Matthew Arnold January 25, 2012

Seven weeks after Pfizer's main Lipitor patent expired in the US, the drug is down to 32% market share and at least one name-brand analyst is casting doubt on the brand's survival strategy.

Merck web widget points to future adherence fix

Matthew Arnold October 04, 2011

Asking consumers to gauge their risk for non-adherence, Merck is deploying a one-minute survey dubbed the Adherence Estimator that may be the way forward for keeping patients on-treatment.

Video Exclusive

Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.